Infection Control and Hospital Epidemiology · 2011 · 81 citations · 5 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial PharmacotherapyAntimicrobial ResistanceMedical MicrobiologyAntibiotic ResistanceAntimicrobial Resistance PreventionBacterial InfectionsEmpiric Antimicrobial TherapyEmpiric Therapy SelectionHealthcare-associated Infection PreventionAntibiotic Susceptibility Data AnalysisDaptomycin ResistanceEmpiric Antibiotic TherapyEnterococciEnterococcus ResistanceResistance Mechanisms In EnterococciVancomycin-resistant Enterococcal InfectionVancomycin-resistant Enterococci
Recent surveillance from US hospitals shows that more than 99.5% of vancomycin-resistant enterococci (VRE) isolates remain susceptible to daptomycin. This report describes emergence of daptomycin-resistant VRE at a major cancer center. The percentage of patients with daptomycin-resistant VRE bacteremia increased from 3.4% in 2007 to 15.2% in 2009 ([Formula: see text]). Without susceptibility data, empiric daptomycin therapy for VRE infections should be used with caution.
5
Resistance Studies with Daptomycin
Jared Silverman, N. Oliver, Ted Andrew et al. · Antimicrobial Agents and Chemotherapy · 2001 · 235 citations · Full text
Hélio S. Sader, Ronald N. Jones · Diagnostic Microbiology and Infectious Disease · 2009 · 101 citations